Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.22.2
Commitments and Contingencies (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 30, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Product Liability Contingency [Line Items]            
Labor and Related Expense       $ 65,834    
Accrued expenses   $ 276,573   276,573   $ 224,949
Research and Development Expense   2,221,339 $ 2,664,979 3,742,703 $ 4,871,853  
Repayments of Related Party Debt       800,000    
Development fees $ 1,000,000.0          
Payment for fees $ 775,000          
Due to related parties         225,000  
Houston Pharmaceuticals [Member]            
Product Liability Contingency [Line Items]            
Cost of Goods and Services Sold       41,075 385,000  
WPD Product Supply Agreement [Member]            
Product Liability Contingency [Line Items]            
Product held at third party depot   655,000   655,000    
WPD Product Supply Agreement [Member] | Upfront Payment [Member]            
Product Liability Contingency [Line Items]            
Due from Other Related Parties, Current   131,073   131,073    
WPD Product Supply Agreement [Member] | Pass Thru Costs [Member]            
Product Liability Contingency [Line Items]            
Due from Other Related Parties, Current   262,145   262,145    
Scientific Advisory Board [Member]            
Product Liability Contingency [Line Items]            
Accrued expenses   $ 65,834   65,834    
Houston Pharm [Member] | Technology Rights Agreement [Member]            
Product Liability Contingency [Line Items]            
Royalty Income, Nonoperating         175,000  
WPD Pharmaceuticals [Member] | Upfront Payment [Member]            
Product Liability Contingency [Line Items]            
Other Nonoperating Income       393,182    
UTMDACC [Member] | Patent And Technology License Agr [Member]            
Product Liability Contingency [Line Items]            
License fee       44,424 22,902  
UTMDACC [Member] | Sponsored Research Agreement [Member]            
Product Liability Contingency [Line Items]            
License fee         334,000  
Research and Development Expense         $ 400,000  
WPD [Member] | Development Agreement [Member]            
Product Liability Contingency [Line Items]            
Development fees       $ 225,000    
Climaco [Member]            
Product Liability Contingency [Line Items]            
Salary and wages           525,000
Silberman [Member]            
Product Liability Contingency [Line Items]            
Salary and wages           200,000
Picker [Member]            
Product Liability Contingency [Line Items]            
Salary and wages           115,000
Downs [Member]            
Product Liability Contingency [Line Items]            
Salary and wages           $ 340,000